Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Role of HPV genotype, multiple infections and viral load on the risk of high-grade cervical neoplasia.

Adcock R, Cuzick J, Hunt WC, McDonald RM, Wheeler CM.

Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: cebp.0239.2019. doi: 10.1158/1055-9965.EPI-19-0239. [Epub ahead of print]

PMID:
31488417
2.

Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.

Cuzick J, Myers O, Lee JH, Shi Y, Gage JC, Hunt WC, Robertson M, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

JAMA Oncol. 2017 Oct 1;3(10):1327-1334. doi: 10.1001/jamaoncol.2017.1040.

3.

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Obstet Gynecol. 2016 Dec;128(6):1248-1257.

4.

Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.

Benard VB, Castle PE, Jenison SA, Hunt WC, Kim JJ, Cuzick J, Lee JH, Du R, Robertson M, Norville S, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

JAMA Oncol. 2017 Jun 1;3(6):833-837. doi: 10.1001/jamaoncol.2016.3609.

5.

Corrigendum to "A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry" [HumAN PatholOGY 2013;44:2542-2548].

Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM.

Hum Pathol. 2016 Jun;52:201. doi: 10.1016/j.humpath.2016.04.001. Epub 2016 May 1. No abstract available.

6.

Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):36-42. doi: 10.1158/1055-9965.EPI-15-0669. Epub 2015 Oct 30.

7.

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.

Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Ann Intern Med. 2015 Oct 20;163(8):589-97. doi: 10.7326/M15-0420. Epub 2015 Sep 29.

8.

The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV Status.

Stoler MH, Ronnett BM, Joste NE, Hunt WC, Cuzick J, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Am J Surg Pathol. 2015 Jun;39(6):729-36. doi: 10.1097/PAS.0000000000000381.

9.

Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.

Cuzick J, Myers O, Hunt WC, Saslow D, Castle PE, Kinney W, Waxman A, Robertson M, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Int J Cancer. 2015 Jun 15;136(12):2854-63. doi: 10.1002/ijc.29337. Epub 2014 Dec 1.

10.

Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.

Joste NE, Ronnett BM, Hunt WC, Pearse A, Langsfeld E, Leete T, Jaramillo M, Stoler MH, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):230-40. doi: 10.1158/1055-9965.EPI-14-0775. Epub 2014 Nov 2.

11.

Concurrence of multiple human papillomavirus infections in a large US population-based cohort.

Yang Z, Cuzick J, Hunt WC, Wheeler CM.

Am J Epidemiol. 2014 Dec 1;180(11):1066-75. doi: 10.1093/aje/kwu267. Epub 2014 Oct 29.

12.

Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test.

Castle PE, Hunt WC, Langsfeld E, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Obstet Gynecol. 2014 Jan;123(1):49-56. doi: 10.1097/AOG.0000000000000013.

13.

Relationships of clinic size, geographic region, and race/ethnicity to the frequency of missed/shortened dialysis treatments.

Obialo C, Zager PG, Myers OB, Hunt WC.

J Nephrol. 2014 Aug;27(4):425-30. doi: 10.1007/s40620-013-0035-y. Epub 2014 Jan 21.

PMID:
24446347
14.

Cervical excisional treatment of young women: a population-based study.

Kinney W, Hunt WC, Dinkelspiel H, Robertson M, Cuzick J, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Gynecol Oncol. 2014 Mar;132(3):628-35. doi: 10.1016/j.ygyno.2013.12.037. Epub 2014 Jan 4.

15.

A population-based evaluation of cervical screening in the United States: 2008-2011.

Cuzick J, Myers O, Hunt WC, Robertson M, Joste NE, Castle PE, Benard VB, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):765-73. doi: 10.1158/1055-9965.EPI-13-0973. Epub 2013 Dec 3.

16.

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.

Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE; New Mexico HPV Pap Registry Steering Committee.

Int J Cancer. 2014 Aug 1;135(3):624-34. doi: 10.1002/ijc.28605. Epub 2014 Apr 15.

17.

No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study.

Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

J Infect Dis. 2014 Mar;209(6):855-64. doi: 10.1093/infdis/jit577. Epub 2013 Oct 31.

18.

A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry.

Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM.

Hum Pathol. 2013 Nov;44(11):2542-8. doi: 10.1016/j.humpath.2013.06.015. Epub 2013 Sep 25. Erratum in: Hum Pathol. 2016 Jun;52:201.

19.

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

de Sanjose S, Wheeler CM, Quint WGV, Hunt WC, Joste NE, Alemany L, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group, Myers ER, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1313-1318. doi: 10.1158/1055-9965.EPI-13-0053. Epub 2013 Apr 30.

20.

Cervical histopathology variability among laboratories: a population-based statewide investigation.

Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Am J Clin Pathol. 2013 Mar;139(3):330-5. doi: 10.1309/AJCPSD3ZXJXP7NNB.

21.

Relationship of missed and shortened hemodialysis treatments to hospitalization and mortality: observations from a US dialysis network.

Obialo CI, Hunt WC, Bashir K, Zager PG.

Clin Kidney J. 2012 Aug;5(4):315-9. doi: 10.1093/ckj/sfs071.

22.

A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.

Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Pearse A, Montoya GD, Robertson M, Shearman CA, Castle PE; New Mexico HPV Pap Registry Steering Committee.

Int J Cancer. 2013 Jan 1;132(1):198-207. doi: 10.1002/ijc.27608. Epub 2012 Jun 20.

23.

Uranium in drinking water: renal effects of long-term ingestion by an aboriginal community.

Zamora ML, Zielinski JM, Moodie GB, Falcomer RA, Hunt WC, Capello K.

Arch Environ Occup Health. 2009 Winter;64(4):228-41. doi: 10.1080/19338240903241267.

PMID:
20007119
24.

Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.

Servilla KS, Singh AK, Hunt WC, Harford AM, Miskulin D, Meyer KB, Bedrick EJ, Rohrscheib MR, Tzamaloukas AH, Johnson HK, Zager PG.

Am J Kidney Dis. 2009 Sep;54(3):498-510. doi: 10.1053/j.ajkd.2009.05.007. Epub 2009 Jul 23.

PMID:
19628315
25.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

26.

Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome.

Pergam SA, Schmidt DW, Nofchissey RA, Hunt WC, Harford AH, Goade DE.

Am J Trop Med Hyg. 2009 Feb;80(2):279-85.

27.

Age-related blood pressure patterns and blood pressure variability among hemodialysis patients.

Rohrscheib MR, Myers OB, Servilla KS, Adams CD, Miskulin D, Bedrick EJ, Hunt WC, Lindsey DE, Gabaldon D, Zager PG; DCI Medical Directors.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1407-14. doi: 10.2215/CJN.00110108. Epub 2008 Aug 13.

28.

Revised norms for the Lollipop Test for children ages 42 to 65 months.

Eno L, Hunt WC, Reynolds T.

Psychol Rep. 2008 Apr;102(2):639-42.

PMID:
18567238
29.

Risk determinants for catheter-associated blood stream infections in children and young adults with cancer.

Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G, Lemon D, Hunt WC, Winter SS.

Pediatr Blood Cancer. 2008 Jul;51(1):53-8. doi: 10.1002/pbc.21497.

PMID:
18266227
30.

Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.

Deshpande A, Wheeler CM, Hunt WC, Peyton CL, White PS, Valdez YE, Nolan JP.

J Infect Dis. 2008 Feb 1;197(3):371-81. doi: 10.1086/524300.

PMID:
18248301
31.

Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?

Tentori F, Hunt WC, Rohrscheib M, Zhu M, Stidley CA, Servilla K, Miskulin D, Meyer KB, Bedrick EJ, Johnson HK, Zager PG.

J Am Soc Nephrol. 2007 Aug;18(8):2377-84. Epub 2007 Jul 18.

32.

Prostate cancer testing following a negative prostate biopsy: over testing the elderly.

Hoffman RM, Denberg T, Hunt WC, Hamilton AS.

J Gen Intern Med. 2007 Aug;22(8):1139-43. Epub 2007 Jun 7.

33.

Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer.

Wheeler CM, Hunt WC, Schiffman M, Castle PE; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group.

J Infect Dis. 2006 Nov 1;194(9):1291-9. Epub 2006 Sep 27.

PMID:
17041856
34.

Mortality risk among hemodialysis patients receiving different vitamin D analogs.

Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc.

Kidney Int. 2006 Nov;70(10):1858-65. Epub 2006 Oct 4.

35.

Ethnic differences in the use of complementary and alternative therapies among adults with osteoarthritis.

Herman CJ, Dente JM, Allen P, Hunt WC.

Prev Chronic Dis. 2006 Jul;3(3):A80. Epub 2006 Jun 15.

36.

Telomere content correlates with stage and prognosis in breast cancer.

Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL, Joste NE, Mangalik A, Baumgartner KB, Baumgartner RN, Hunt WC, Griffith JK.

Breast Cancer Res Treat. 2006 Sep;99(2):193-202. Epub 2006 Jun 3.

PMID:
16752076
37.

Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.

Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM.

Am J Med. 2006 May;119(5):418-25.

PMID:
16651054
38.

Changing relationship of blood pressure with mortality over time among hemodialysis patients.

Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc.

J Am Soc Nephrol. 2006 Feb;17(2):513-20. Epub 2006 Jan 5.

39.

A randomized trial assessing the utility of a test-dose program with taxanes.

Stanford BL, Shah SR, Ballard EE, Jumper CA, Rabinowitz I, Dowell JE, Hunt WC, Krieger JA.

Curr Med Res Opin. 2005 Oct;21(10):1611-6.

PMID:
16238901
40.

TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.

Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM.

J Infect Dis. 2005 Mar 15;191(6):969-76. Epub 2005 Feb 8.

PMID:
15717274
41.

Use of complementary therapies among primary care clinic patients with arthritis.

Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ.

Prev Chronic Dis. 2004 Oct;1(4):A12. Epub 2004 Sep 15.

42.

Association between cancer-free survival and telomere DNA content in prostate tumors.

Fordyce CA, Heaphy CM, Joste NE, Smith AY, Hunt WC, Griffith JK.

J Urol. 2005 Feb;173(2):610-4.

PMID:
15643274
43.

Association of body composition and weight history with breast cancer prognostic markers: divergent pattern for Hispanic and non-Hispanic White women.

Baumgartner KB, Hunt WC, Baumgartner RN, Crumley DD, Gilliland FD, McTiernan A, Bernstein L, Ballard-Barbash R.

Am J Epidemiol. 2004 Dec 1;160(11):1087-97.

PMID:
15561988
44.

Acute changes in cortical excitability in the cortex contralateral to focal intracerebral hemorrhage in the swine.

Mun-Bryce S, Roberts LJ, Hunt WC, Bartolo A, Okada Y.

Brain Res. 2004 Nov 12;1026(2):218-26.

PMID:
15488483
45.

Accuracy of alcohol diagnosis among DWI offenders referred for screening.

Lapham SC, C'de Baca J, McMillan G, Hunt WC.

Drug Alcohol Depend. 2004 Nov 11;76(2):135-41.

PMID:
15488337
46.

Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls.

Hoffman RM, Gilliland FD, Penson DF, Stone SN, Hunt WC, Potosky AL.

Cancer. 2004 Nov 1;101(9):2011-9.

47.

Psychiatric disorders of convicted DWI offenders: a comparison among Hispanics, American Indians and non-Hispanic whites.

C'de Baca J, Lapham SC, Skipper BJ, Hunt WC.

J Stud Alcohol. 2004 Jul;65(4):419-27.

PMID:
15376815
48.

Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico.

Athas WF, Hunt WC, Key CR.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1105-8.

49.

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.

Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL.

J Gen Intern Med. 2003 Oct;18(10):845-53.

50.

Effects of misattribution in assigning cause of death on prostate cancer mortality rates.

Hoffman RM, Stone SN, Hunt WC, Key CR, Gilliland FD.

Ann Epidemiol. 2003 Jul;13(6):450-4.

PMID:
12875804

Supplemental Content

Support Center